User:Mr. Ibrahem/Alogliptin

Alogliptin, sold under the brand names Nesina and Vipidia among others, is a medication used to treat type 2 diabetes. It is a second line treatment used together with diet and exercise. Effects on the risk of heart disease are unclear. It is taken by mouth.

Common side effects include runny nose, headache, and upper respiratory tract infection. Other side effects may include pancreatitis, heart failure, anaphylaxis, liver problems, and low blood sugar. Safety in pregnancy is unclear. It is a DPP-4 inhibitor (gliptin), which works by increasing insulin secretion from the pancreas.

Alogliptin was approved for medical use in the United States and Europe in 2013. In the United Kingdom 4 weeks costs the NHS about £27 as of 2021. This amount in the United States is about 90 USD. It is also available as a combination medication with metformin or pioglitazone.